Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublications en collaboration avec des chercheurs de Instituto de Biomedicina de Sevilla (14)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
Journal of Proteome Research, Vol. 22, Núm. 11, pp. 3499-3507
2022
-
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 74, Núm. 5, pp. 757-765
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma: Diagnosis of NAFLD-HCC utilising serum lipidomics
EBioMedicine, Vol. 73
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
2018
-
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation
Clinical Microbiology and Infection, Vol. 24, Núm. 2, pp. 192-198
2017
-
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
The Lancet, Vol. 389, Núm. 10064, pp. 67-76
-
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8
2016
-
Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 11, pp. 3220-3234
-
Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study
American Journal of Transplantation, Vol. 16, Núm. 7, pp. 2148-2157
-
The cancer stem-cell signaling network and resistance to therapy
Cancer Treatment Reviews, Vol. 49, pp. 25-36